Investment House LLC reduced its holdings in Molina Healthcare, Inc (NYSE:MOH - Free Report) by 15.3% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 164,196 shares of the company's stock after selling 29,555 shares during the period. Molina Healthcare comprises about 1.4% of Investment House LLC's holdings, making the stock its 15th largest holding. Investment House LLC owned approximately 0.31% of Molina Healthcare worth $31,049,000 at the end of the most recent quarter.
Several other hedge funds have also recently bought and sold shares of the business. BlackRock Inc. acquired a new stake in shares of Molina Healthcare in the 2nd quarter valued at approximately $1,503,052,000. Manning & Napier Advisors LLC acquired a new position in shares of Molina Healthcare during the 2nd quarter worth about $152,339,000. Maverick Capital Ltd. bought a new position in shares of Molina Healthcare during the 1st quarter worth approximately $86,081,000. Bank of New York Mellon Corp bought a new stake in shares of Molina Healthcare during the second quarter worth approximately $86,138,000. Finally, Bank of America Corp DE acquired a new stake in Molina Healthcare during the second quarter worth approximately $71,480,000. 98.50% of the stock is owned by institutional investors and hedge funds.
Molina Healthcare Trading Up 0.8%
Molina Healthcare stock opened at $216.55 on Friday. Molina Healthcare, Inc has a 12-month low of $121.06 and a 12-month high of $244.89. The firm has a 50 day moving average of $200.71 and a 200 day moving average of $196.06. The company has a current ratio of 1.68, a quick ratio of 1.68 and a debt-to-equity ratio of 0.95. The firm has a market capitalization of $11.30 billion, a price-to-earnings ratio of 107.45, a P/E/G ratio of 30.81 and a beta of 0.78.
Molina Healthcare (NYSE:MOH - Get Free Report) last issued its quarterly earnings results on Wednesday, October 21st. The company reported $0.89 earnings per share for the quarter, topping the consensus estimate of $0.79 by $0.10. Molina Healthcare had a negative net margin of 0.11% and a positive return on equity of 2.51%. The company had revenue of $11.08 billion for the quarter, compared to the consensus estimate of $10.86 billion. During the same quarter in the prior year, the company earned $1.84 EPS. Molina Healthcare's quarterly revenue was down 3.4% on a year-over-year basis. As a group, research analysts predict that Molina Healthcare, Inc will post 5.28 earnings per share for the current year.
More Molina Healthcare News
Here are the key news stories impacting Molina Healthcare this week:
- Positive Sentiment: Adjusted earnings were $0.89 per share, above the $0.79 consensus estimate, while revenue of $11.08 billion exceeded expectations of $10.86 billion. The earnings beat likely provided near-term support for the stock. Molina Healthcare third-quarter results
- Positive Sentiment: Management reaffirmed its 2026 outlook, including approximately $42 billion in premium revenue and at least $2.38 in GAAP earnings per diluted share. Operating cash flow reached $629 million through the first nine months, supporting the company’s financial position. Molina Healthcare GAAP earnings report
- Neutral Sentiment: The earnings call is likely to remain important for investors seeking details on Medicaid profitability, the new Florida contract and Molina’s planned 2027 exit from its traditional Medicare Advantage Part D product. Molina Healthcare Q3 2026 earnings call transcript
- Negative Sentiment: Underlying results deteriorated year over year. GAAP net income fell to $38 million from $79 million, or $0.73 per share versus $1.51, while premium revenue declined 4% and membership fell to approximately 4.9 million. The medical care ratio also increased to 92.9% from 92.6%, signaling ongoing medical-cost and margin pressure. Molina Healthcare lower third-quarter profit
Analyst Ratings Changes
A number of brokerages have recently commented on MOH. TD Cowen lifted their price target on Molina Healthcare from $163.00 to $230.00 and gave the company a "hold" rating in a research note on Tuesday, July 14th. Truist Financial lowered their price target on Molina Healthcare from $250.00 to $225.00 and set a "hold" rating for the company in a research report on Friday, July 24th. Barclays reduced their price objective on Molina Healthcare from $184.00 to $180.00 and set an "underweight" rating for the company in a research note on Friday, July 24th. Wells Fargo & Company dropped their target price on shares of Molina Healthcare from $235.00 to $220.00 and set an "equal weight" rating on the stock in a research note on Tuesday, July 28th. Finally, Cantor Fitzgerald reiterated a "neutral" rating on shares of Molina Healthcare in a research note on Friday, October 9th. Three investment analysts have rated the stock with a Buy rating, twelve have issued a Hold rating and two have given a Sell rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of "Hold" and a consensus price target of $202.44.
View Our Latest Research Report on Molina Healthcare
About Molina Healthcare
(
Free Report)
Molina Healthcare, Inc is a managed-care company that provides health insurance and related services primarily through government-sponsored programs. Its offerings include Medicaid, Medicare, Medicare-Medicaid dual-eligible plans and health plans sold through government marketplaces under the Affordable Care Act.
The company's services generally include medical care coordination, behavioral health support, pharmacy benefits and, depending on the plan and state, dental and vision benefits.
Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Molina Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Molina Healthcare wasn't on the list.
While Molina Healthcare currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.